German multicenter trials for adult ALL (GMALL) also showed that CD10 negative pre-B ALL is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.